D-381-2014 Class I Terminated
FDA drug recall D-381-2014 was initiated by Hospira Inc. on Jul 12, 2013 and is designated Class I. Reason for recall: Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials. The recall status is terminated (terminated Feb 3, 2015). Affected quantity: 119,600 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 25, 2013
- Initiation Date
- Jul 12, 2013
- Termination Date
- Feb 3, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 119,600 vials
Product Description
0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02
Reason for Recall
Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.
Distribution Pattern
Nationwide
Code Information
Lot # 23-338-DK, Exp. 11/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-381-2014
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026